• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Daily home spirometry to detect early steroid treatment effects in newly treated pulmonary sarcoidosis.

作者信息

Broos Caroline E, Wapenaar Monique, Looman Caspar W N, In 't Veen Johannes C C M, van den Toorn Leon M, Overbeek Maria J, Grootenboers Marco J J H, Heller Roxane, Mostard Rémy L, Poell Linda H C, Hoogsteden Henk C, Kool Mirjam, Wijsenbeek Marlies S, van den Blink Bernt

机构信息

Dept of Pulmonary Medicine, Erasmus MC, Rotterdam, The Netherlands.

Dept of Public Health, Erasmus MC, Rotterdam, The Netherlands.

出版信息

Eur Respir J. 2018 Jan 18;51(1). doi: 10.1183/13993003.02089-2017. Print 2018 Jan.

DOI:10.1183/13993003.02089-2017
PMID:29348185
Abstract
摘要

相似文献

1
Daily home spirometry to detect early steroid treatment effects in newly treated pulmonary sarcoidosis.采用每日家庭肺量计检测新治疗的结节病患者早期类固醇治疗效果。
Eur Respir J. 2018 Jan 18;51(1). doi: 10.1183/13993003.02089-2017. Print 2018 Jan.
2
Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study.一项评估甲氨蝶呤与泼尼松作为肺结节病一线治疗方案有效性的随机对照试验设计：PREDMETH 研究。
BMC Pulm Med. 2020 Oct 19;20(1):271. doi: 10.1186/s12890-020-01290-9.
3
[Effect of bronchoalveolar lavage (BAL) on gasometric and spirometric parameters in patients with sarcoidosis].[支气管肺泡灌洗（BAL）对结节病患者气体测量和肺量计参数的影响]
Pneumonol Alergol Pol. 1994;62(11-12):623-7.
4
Alternate day steroid therapy in diffuse pulmonary sarcoidosis.弥漫性肺结节病的隔日类固醇疗法。
Chest. 1973 Apr;63(4):495-504. doi: 10.1378/chest.63.4.495.
5
A home monitoring program including real-time wireless home spirometry in idiopathic pulmonary fibrosis: a pilot study on experiences and barriers.特发性肺纤维化患者家庭监测方案：实时无线家庭肺功能测定的试点研究——经验与障碍
Respir Res. 2018 May 29;19(1):105. doi: 10.1186/s12931-018-0810-3.
6
The quality of home spirometry in school children with asthma.哮喘学龄儿童家庭肺功能测定的质量
Thorax. 2001 Mar;56(3):183-5. doi: 10.1136/thorax.56.3.183.
7
A composite score to assess treatment response in pulmonary sarcoidosis: the Sarcoidosis Treatment Score (STS).评估结节病治疗反应的综合评分：结节病治疗评分（STS）。
Sarcoidosis Vasc Diffuse Lung Dis. 2019;36(1):86-88. doi: 10.36141/svdld.v36i1.7748. Epub 2019 May 1.
8
Six-minute walk test and health status assessment in sarcoidosis.结节病的六分钟步行试验与健康状况评估
Chest. 2007 Jul;132(1):207-13. doi: 10.1378/chest.06-2822.
9
Pulmonary sarcoidosis: a prospective evaluation of glucocorticoid therapy.肺结节病：糖皮质激素治疗的前瞻性评估
Ann Intern Med. 1970 Aug;73(2):207-12. doi: 10.7326/0003-4819-73-2-207.
10
Inhaled budesonide vs prednisone in the maintenance treatment of pulmonary sarcoidosis.吸入布地奈德与泼尼松用于结节病维持治疗的比较
Sarcoidosis. 1993 Mar;10(1):56-61.

引用本文的文献

1
The role of digital health in respiratory diseases management: a narrative review of recent literature.数字健康在呼吸系统疾病管理中的作用：近期文献综述
Front Med (Lausanne). 2025 Feb 26;12:1361667. doi: 10.3389/fmed.2025.1361667. eCollection 2025.
2
Increased proportions of circulating PD-1 CD4 memory T cells and PD-1 regulatory T cells associate with good response to prednisone in pulmonary sarcoidosis.循环 PD-1 CD4 记忆 T 细胞和 PD-1 调节性 T 细胞比例增加与肺结节病对泼尼松的良好反应相关。
Respir Res. 2024 May 7;25(1):196. doi: 10.1186/s12931-024-02833-y.
3
Treatment of Granulomatous Inflammation in Pulmonary Sarcoidosis.
肺结节病中肉芽肿性炎症的治疗
J Clin Med. 2024 Jan 27;13(3):738. doi: 10.3390/jcm13030738.
4
Supporting self-management for patients with Interstitial Lung Diseases: Utility and acceptability of digital devices.支持间质性肺疾病患者的自我管理：数字设备的效用和可接受性。
PLOS Digit Health. 2024 Jan 8;3(1):e0000318. doi: 10.1371/journal.pdig.0000318. eCollection 2024 Jan.
5
Pulmonary Function in Pulmonary Sarcoidosis.肺结节病的肺功能
J Clin Med. 2023 Oct 24;12(21):6701. doi: 10.3390/jcm12216701.
6
Exposure-response analyses of efzofitimod in patients with pulmonary sarcoidosis.肺结节病患者中依佐替莫德的暴露-反应分析。
Front Pharmacol. 2023 Oct 3;14:1258236. doi: 10.3389/fphar.2023.1258236. eCollection 2023.
7
The Symptoms of Pulmonary Sarcoidosis.肺结节病的症状。
J Clin Med. 2023 Sep 20;12(18):6088. doi: 10.3390/jcm12186088.
8
Holistic management of patients with progressive pulmonary fibrosis.进行性肺纤维化患者的整体管理
Breathe (Sheff). 2023 Sep;19(3):230101. doi: 10.1183/20734735.0101-2023. Epub 2023 Sep 12.
9
Unsupervised home spirometry supervised clinic spirometry for respiratory disease: a systematic methodology review and meta-analysis.无监督家庭肺量计与有监督临床肺量计在呼吸疾病中的应用：系统方法学评价和荟萃分析。
Eur Respir Rev. 2023 Sep 6;32(169). doi: 10.1183/16000617.0248-2022. Print 2023 Sep 30.
10
Optimizing the safety of antibody-drug conjugates for patients with solid tumours.优化抗体药物偶联物在实体瘤患者中的安全性。
Nat Rev Clin Oncol. 2023 Aug;20(8):558-576. doi: 10.1038/s41571-023-00783-w. Epub 2023 Jun 9.